Hospital Doctor Balmis participates in international trial against rare blood cancer
The Alicante centre joins a global clinical study to improve treatment of myelofibrosis, a rare cancer affecting the bone marrow.
Hospital General Universitario Doctor Balmis de Alicante is taking part in an international clinical trial aimed at advancing the treatment of myelofibrosis, a rare form of haematological cancer that damages the bone marrow.
This global research seeks to develop new therapies and management protocols for patients with this uncommon disease, improving their quality of life and prognosis.
The Alicante centre’s participation reinforces its position as a reference in oncological research and enables local patients to access innovative treatments within a controlled research framework.
Myelofibrosis affects the bone marrow’s ability to produce normal blood cells, causing serious complications that require ongoing specialised care.
Source: informacion.es
Related news
- GeneralUMH in Elche drives innovative healthcare and biotechnology projects at its Start-up Marathon
The 15th Start-up Creation Marathon at Miguel Hernández University recognises projects including an early Parkinson's detection kit and biotechnology platforms.
- GeneralThe CHS receives recognition from the King for its centenary
The Confederación Hidrográfica del Segura has been recognised by King Felipe VI upon reaching one hundred years since its creation.